<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38274115</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study.</ArticleTitle><Pagination><StartPage>102398</StartPage><MedlinePgn>102398</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102398</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2023.102398</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Post-COVID-19 condition has recently been defined as new or persistent common COVID-19 symptoms occurring three months after disease onset. The pathology of the disease is unclear, but immune and vascular factors seem to play a significant role. The incidence, severity, and implications of the disease after COVID-19 infection in pregnancy have not been established. We aimed to study the incidence and main risk factors for post-COVID-19 condition in an obstetric population and their implications for maternal and perinatal morbimortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This is a prospective observational cohort study undertaken including women during pregnancy or at admission for labour with acute COVID-19 infection from March 9th, 2020 to June 11th, 2022. The inclusion criteria were confirmed acute COVID-19 infection during the recruitment period, a lack of significant language barrier and consent for follow-up. Patients were clinically followed-up by telephone via semi structured questionnaires. The exclusion criteria were loss to follow-up, spontaneous miscarriage, and legal termination of pregnancy. Patients were classified into groups according to the severity of symptoms at onset. We included patients from the first six first waves of the pandemic according to national epidemiological data in Spain. We studied the incidence of post-COVID-19 condition and their main demographic, clinical and obstetric risk factors.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">A total of 409 pregnant women were recruited at acute diagnosis, and 286 were followed-up. The mean time to follow-up was 92 weeks (standard deviation&#xa0;&#xb1;&#xa0;28 weeks; median 100 weeks (Interquartile range: 76; 112)). A total of 140 patients had at least one post-COVID-19 symptom at least three months after acute infection. Neurological (60%) and cutaneous (55%) manifestations were the most frequent findings. The following profiles were identified as presenting a higher risk of post-COVID-19 condition: migrant women born in countries with lower Human Development Index; multiparous women; women with COVID-19 during pregnancy, mainly during the first and third trimesters, and in the first and second waves of the pandemic; women who had a higher number of symptoms; women who had a higher incidence of moderate and severe symptoms; women who required hospitalisation due to COVID-19 complications; and women who were not vaccinated before disease onset. We did not find any significant difference in perinatal results, such as gestational week at delivery, birthweight, the need for neonatal care or 5-min Apgar score, and newborns benefited from a high rate of breastfeeding at discharge. Women who were infected during successive waves of the pandemic had a significant and constant decrease in the risk of post-COVID-19 condition comparing to estimated risk in the first wave (OR: 0.70; 95% CI: 0.62, 0.92). Symptoms tended to resolve over time heterogeneously. Symptoms of myalgia and arthralgia took longer to resolve (mean of 60 weeks and 54 weeks, respectively). In a small but significant proportion of patients, neurological and psycho-emotional symptoms tended to become chronic after 90 weeks.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">At least 34.2% of obstetric patients from our cohort with acute COVID-19 infection presented post-COVID-19 condition symptoms. Demographic and acute disease characteristics as well as specific pregnancy-related risk factors were identified. This is the first study to assess post-COVID-19 condition in pregnant women. Further analysis on the biological pathophysiology of post-COVID-19 is needed to explain the characteristics of the disease.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project "PI21/01244" and co-funded by the European Union, as well as P2022/BMD-7321 (Comunidad de Madrid) and ProACapital, Halekulani S.L. and MJR.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Ch&#xe1;puli Guti&#xe9;rrez</LastName><ForeName>Mar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public and Maternal and Child Health, Faculty of Medicine and Health Science, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prat</LastName><ForeName>Ainoa S&#xe1;ez</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vila</LastName><ForeName>Ana Dur&#xe1;n</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Public and Maternal and Child Health, Faculty of Medicine and Health Science, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital Quir&#xf3;n Salud Valle del Henares, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claverol</LastName><ForeName>Mireia Bernal</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Pilar Pay&#xe1;</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recarte</LastName><ForeName>Pilar Pintado</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Public and Maternal and Child Health, Faculty of Medicine and Health Science, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben&#xe9;itez</LastName><ForeName>Mamen Vi&#xf1;uela</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Public and Maternal and Child Health, Faculty of Medicine and Health Science, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Cristina Aus&#xed;n</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Eva Cervilla</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public and Maternal and Child Health, Faculty of Medicine and Health Science, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatric Infectious Diseases, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERINFEC, Instituto de Salud Carlos III (ISCIII), Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>Pablo Gonz&#xe1;lez</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Maternal and Paediatric Research (Fundaci&#xf3;n Familia Alonso (UDIMIFFA)) - Institute of Health Investigation Gregorio Mara&#xf1;&#xf3;n (IiSGM), Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Mon</LastName><ForeName>Melchor</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal&#xe1;&#xb0;, Alcal&#xe1;&#xb0; de Henares, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ram&#xf3;n y Cajal Institute of Sanitary Research IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune System Diseases-Rheumatology and Internal Medicine Service, University Hospital Pr&#xed;ncipe de Asturias, CIBEREHD, Alcal&#xe1;&#xb0; de Henares, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcal&#xe1;&#xb0;, Alcal&#xe1;&#xb0; de Henares, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ram&#xf3;n y Cajal Institute of Sanitary Research IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Le&#xf3;n-Lu&#xed;s</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Public and Maternal and Child Health, Faculty of Medicine and Health Science, School of Medicine, Complutense University of Madrid, Madrid 28040, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Research Institute, Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid 28009, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Obstetrics</Keyword><Keyword MajorTopicYN="N">Perinatal</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword><Keyword MajorTopicYN="N">Postpartum</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList><CoiStatement>We report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38274115</ArticleId><ArticleId IdType="pmc">PMC10809073</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2023.102398</ArticleId><ArticleId IdType="pii">S2589-5370(23)00575-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  World health statistics. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</Citation></Reference><Reference><Citation>Chu D.K., Akl E.A., Duda S., Solo K., Yaacoub S., Sch&#xfc;nemann H.J. COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973&#x2013;1987. doi: 10.1016/S0140-6736(20)31142-9. Epub 2020 Jun 1. PMID: 32497510; PMCID: PMC7263814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31142-9</ArticleId><ArticleId IdType="pmc">PMC7263814</ArticleId><ArticleId IdType="pubmed">32497510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cena L., Rota M., Calza S., Massardi B., Trainini A., Stefana A. Estimating the impact of the COVID-19 pandemic on maternal and perinatal health care services in Italy: results of a self-administered survey. Front Public Health. 2021;9 doi: 10.3389/fpubh.2021.701638. PMID: 34336776; PMCID: PMC8323996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.701638</ArticleId><ArticleId IdType="pmc">PMC8323996</ArticleId><ArticleId IdType="pubmed">34336776</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oosterhout C., Hall N., Ly H., Tyler K.M. COVID-19 evolution during the pandemic - implications of new SARS-CoV-2 variants on disease control and public health policies. Virulence. 2021;12(1):507&#x2013;508. doi: 10.1080/21505594.2021.1877066. PMID: 33494661; PMCID: PMC7849743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2021.1877066</ArticleId><ArticleId IdType="pmc">PMC7849743</ArticleId><ArticleId IdType="pubmed">33494661</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchand G., Patil A.S., Masoud A.T., et al. Systematic review and meta-analysis of COVID maternal and neonatal clinical features and pregnancy outcomes to June 3rd 2021. AJOG Glob Rep. 2022;2 doi: 10.1016/j.xagr.2021.100049. Epub ahead of print. PMID: 35005663; PMCID: PMC8720679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xagr.2021.100049</ArticleId><ArticleId IdType="pmc">PMC8720679</ArticleId><ArticleId IdType="pubmed">35005663</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J., Stallings E., Bonet M., et al. For PregCOV-19 Living Systematic Review Consortium Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370 doi: 10.1136/bmj.m3320. PMID: 32873575; PMCID: PMC7459193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3320</ArticleId><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz T.D., Clifton R.G., Hughes B.L., et al. National Institute of child health and human development maternal-fetal medicine units (MFMU) network Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022;327 doi: 10.1001/jama.2022.1190. Epub ahead of print. PMID: 35129581; PMCID: PMC8822445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.1190</ArticleId><ArticleId IdType="pmc">PMC8822445</ArticleId><ArticleId IdType="pubmed">35129581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P.L., Nouhin J., et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22(12):757&#x2013;773. doi: 10.1038/s41576-021-00408-x. Epub 2021 Sep 17. PMID: 34535792; PMCID: PMC8447121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO clinical case definition working group on post-COVID-19 condition A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9. Epub ahead of print. PMID: 34951953; PMCID: PMC8691845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22. PMID: 34024217; PMCID: PMC8146298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9) doi: 10.1136/bmjgh-2021-005427. PMID: 34580069; PMCID: PMC8478580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x. Epub 2021 Jul 28. PMID: 34319569; PMCID: PMC8317481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez M.M., Dur&#xe1;n-Vila A., Ruiz-Labarta J., et al. A&#xa0;new multiplatform model for outpatient prenatal and postpartum care in a cohort of COVID-19-affected obstetric patients. Int J Environ Res Public Health. 2021;18(10):5144. doi: 10.3390/ijerph18105144. PMID: 34066255; PMCID: PMC8152008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105144</ArticleId><ArticleId IdType="pmc">PMC8152008</ArticleId><ArticleId IdType="pubmed">34066255</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  World health statistics. 2022. https://www.who.int/countries/esp/</Citation></Reference><Reference><Citation>Cu&#xf1;arro-L&#xf3;pez Y., Larroca S.G., Pintado-Recarte P., et al. Influence of the human development Index on the maternal-perinatal morbidity and mortality of pregnant women with SARS-CoV-2 infection: importance for personalized medical care. J&#xa0;Clin Med. 2021;10(16):3631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8396815</ArticleId><ArticleId IdType="pubmed">34441928</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO global clinical platform for COVID-19 case report form (CRF) for COVID-19 sequelae (post COVID-19 CRF) 2021. revised 15 July 2021.</Citation></Reference><Reference><Citation>Duffy J., Rolph R., Gale C., et al. International Collaboration to Harmonise Outcomes in Pre-eclampsia (iHOPE) Core outcome sets in women&#x2019;s and newborn health: a systematic review. BJOG. 2017;124(10):1481&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421657</ArticleId></ArticleIdList></Reference><Reference><Citation>Evolution of pandemic in Spain, Ministry of Health, Spain Government. https://cnecovid.isciii.es/covid19/#evoluci%C3%B3n-pandemia</Citation></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11(2):269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B., Daines L., Han Q., et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. Eur Respir Rev. 2022;31(166)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724798</ArticleId><ArticleId IdType="pubmed">36323418</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.D., Shing J.S.Y., Lin J., Bosanquet K., Fong D.Y.T., Lok K.Y.W. Meta-analysis of diagnostic properties of the Whooley questions to identify depression in perinatal women. J&#xa0;Affect Disord. 2022;315:148&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">35931230</ArticleId></ArticleIdList></Reference><Reference><Citation>Antenatal and postnatal mental health: clinical management and service guidance Clinical guideline [CG192] National Institute for Health and Care Excellence (NICE; 2014. updated 2020 Feb 11)</Citation><ArticleIdList><ArticleId IdType="pubmed">31990493</ArticleId></ArticleIdList></Reference><Reference><Citation>Reivan-Ortiz G., Pineda-Garcia G., Le&#xf3;n-Parias B.D. Psychometric properties of the Goldberg anxiety and depression scale (GADS) in Ecuadorian population. Int J Psychol Res. 2019;12(1):41&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110168</ArticleId><ArticleId IdType="pubmed">32612786</ArticleId></ArticleIdList></Reference><Reference><Citation>Spoont M.R., Williams J.W., Jr., Kehle-Forbes S., Nieuwsma J.A., Mann-Wrobel M.C., Gross R. Does this patient have posttraumatic stress disorder?: rational clinical examination systematic review. JAMA. 2015;314(5):501&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">26241601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearney D.J., Simpson T.L. Broadening the approach to posttraumatic stress disorder and the consequences of trauma (Editorial) JAMA. 2015;314(5):453&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">26241596</ArticleId></ArticleIdList></Reference><Reference><Citation>Shechter A., Chiuzan C., Shang Y., et al. Prevalence, incidence, and factors associated with posttraumatic stress at three-month follow-up among new york city healthcare workers after the first wave of the COVID-19 pandemic. Int J Environ Res Public Health. 2021;19(1):262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8750525</ArticleId><ArticleId IdType="pubmed">35010524</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles J.N., Marshall G.N., Schell T.L. Spanish and English versions of the PTSD Checklist-Civilian version (PCL-C): testing for differential item functioning. J&#xa0;Trauma Stress. 2008;21(4):369&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2958820</ArticleId><ArticleId IdType="pubmed">18720394</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco I., Mu&#xf1;oz-Chapuli M., Vigil-V&#xe1;zquez S., et al. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave. BMC Pregnancy Childbirth. 2021;21(1):326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072086</ArticleId><ArticleId IdType="pubmed">33902483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C., Forsberg G., Divanoglou A., et al. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. Lancet Reg Health Eur. 2023;28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9951394</ArticleId><ArticleId IdType="pubmed">36855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong A.S.F., Pearson R.M., Adams M.J., et al. Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts. Br J Psychiatry. 2021;218(6):334&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844173</ArticleId><ArticleId IdType="pubmed">33228822</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open. 2021;4(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;sconez-Gonz&#xe1;lez J., Fernandez-Naranjo R., Izquierdo-Condoy J.S., et al. Comparative analysis of long-term self-reported COVID-19 symptoms among pregnant women. J&#xa0;Infect Public Health. 2023;16(3):430&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9851727</ArticleId><ArticleId IdType="pubmed">36736066</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J&#xa0;Infect Dis. 2022;226(9):1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R., Shunmugam L., Naidoo K., et al. Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol. 2023;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M., Mudara C., Vika C., et al. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Global Health. 2022;10(9):e1247&#x2013;e1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Erinoso O. Post-COVID-19 condition: current evidence and unanswered questions. Lancet Global Health. 2022;10(9):e1210&#x2013;e1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363039</ArticleId><ArticleId IdType="pubmed">35961329</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Pellicer-Valero O.J., Navarro-Pardo E., et al. Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: the LONG-COVID-EXP-CM multicenter study. Int J Infect Dis. 2022;116:241&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743274</ArticleId><ArticleId IdType="pubmed">35017102</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>